TY - JOUR
T1 - Prognostic value of combined tumor marker and controlling nutritional status (CONUT) score in colorectal cancer patients
AU - Yamamoto, Manabu
AU - Saito, Hiroaki
AU - Uejima, Chihiro
AU - Tanio, Akimitsu
AU - Tada, Yoichiro
AU - Matsunaga, Tomoyuki
AU - Sakamoto, Teruhisa
AU - Honjo, Soichiro
AU - Ashida, Keigo
AU - Fujiwara, Yoshiyuki
N1 - Publisher Copyright:
© 2019, Tottori University Faculty of Medicine. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Background Nutritional status is strongly associated with prognosis in cancer patients. Controlling Nutritional Status (CONUT) score is a nutritional marker based on serum albumin, cholesterol, and total lymphocyte count. We investigated the prognostic significance of a combination of the tumor marker carcinoembryonic antigen (CEA) and CONUT score (T-CONUT) in colorectal cancer (CRC) patients. Methods A total of 522 patients who underwent surgery for CRC at our hospital were retrospectively enrolled in this study. Results Patients were divided into groups based on the results of receiver operating characteristic (ROC) curve analysis as follows: CONUThigh (CONUT score ≥ 3) and CONUTlow (CONUT score < 3), and CEAlow (< 5 ng/mL) and CEAhigh (≥ 5 ng/mL). The 5-year overall survival (OS) rates of patients in the CONUTlow and CONUThigh groups were 76.0% and 53.9%, respectively (P < 0.0001), and in the CEAlow and CEAhigh groups were 80.7% and 47.6%, respectively (P < 0.0001). Regarding T-CONUT, the 5-year OS rates of patients with CEAlow/CONUTlow, CEAlow/CONUThigh, CEAhigh/CONUTlow, and CEAhigh/ CONUThigh were 84.7%, 69%, 55.3%, and 36.1%, respectively (P < 0.0001). Multivariate analysis identified T-CONUT score as an independent prognostic indicator in CRC patients. Conclusion T-CONUT may be a useful tool for predicting prognosis in CRC patients.
AB - Background Nutritional status is strongly associated with prognosis in cancer patients. Controlling Nutritional Status (CONUT) score is a nutritional marker based on serum albumin, cholesterol, and total lymphocyte count. We investigated the prognostic significance of a combination of the tumor marker carcinoembryonic antigen (CEA) and CONUT score (T-CONUT) in colorectal cancer (CRC) patients. Methods A total of 522 patients who underwent surgery for CRC at our hospital were retrospectively enrolled in this study. Results Patients were divided into groups based on the results of receiver operating characteristic (ROC) curve analysis as follows: CONUThigh (CONUT score ≥ 3) and CONUTlow (CONUT score < 3), and CEAlow (< 5 ng/mL) and CEAhigh (≥ 5 ng/mL). The 5-year overall survival (OS) rates of patients in the CONUTlow and CONUThigh groups were 76.0% and 53.9%, respectively (P < 0.0001), and in the CEAlow and CEAhigh groups were 80.7% and 47.6%, respectively (P < 0.0001). Regarding T-CONUT, the 5-year OS rates of patients with CEAlow/CONUTlow, CEAlow/CONUThigh, CEAhigh/CONUTlow, and CEAhigh/ CONUThigh were 84.7%, 69%, 55.3%, and 36.1%, respectively (P < 0.0001). Multivariate analysis identified T-CONUT score as an independent prognostic indicator in CRC patients. Conclusion T-CONUT may be a useful tool for predicting prognosis in CRC patients.
UR - http://www.scopus.com/inward/record.url?scp=85065159296&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065159296&partnerID=8YFLogxK
U2 - 10.33160/yam.2019.03.017
DO - 10.33160/yam.2019.03.017
M3 - Article
AN - SCOPUS:85065159296
SN - 0513-5710
VL - 62
SP - 124
EP - 130
JO - Yonago Acta Medica
JF - Yonago Acta Medica
IS - 1
ER -
